Latest Adenocarcinoma Stories
Medically treated patients with mild or no symptoms of gastroesophageal reflux disease (GERD) are at higher risk for developing esophageal cancer than those with severe GERD symptoms.
As part of The Cancer Genome Atlas (TCGA) projectIcon indicating that a link will open an external site., UNC Lineberger researchers have contributed to the most comprehensive and integrated view of cancer genes for any cancer type produced to date.
A key for early diagnosis of cancer and personalized medicine is the order of genetic aberrations - deviations or irregularity - in individual cancers.
EXTON, Pa., June 28, 2011 /PRNewswire/ -- MorphotekÂ®, Inc., a subsidiary of Eisai Inc., announced today that it has commenced a multi-center phase II study of farletuzumab in adenocarcinoma of the lung, a type of non-small cell lung cancer (NSCLC).
INDIANAPOLIS, June 5, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that PARAMOUNT, its Phase III study evaluating ALIMTAÂ® (pemetrexed for injection) in the continuation maintenance setting, met its primary endpoint of progression-free survival, or the time a patient is alive without their disease worsening, for patients with a specific type of lung cancer called advanced nonsquamous non-small cell lung cancer (NSCLC). "Continuation maintenance" treatment is when...
MANHATTAN BEACH, Calif., May 20, 2011 /PRNewswire/ -- The Pfizer drug SutentÂ® (sunitinib) has been approved for the treatment of advanced pancreatic neuroendocrine tumors by the U.S. Food and Drug Administration (FDA).
A simple, minimally-invasive technique using cells from the interior of the nose could help clinicians detect lung cancer in its earliest â€“ and most treatable â€“ stages.
MANHATTAN BEACH, Calif., May 6, 2011 /PRNewswire/ -- Yesterday, the U.S. Food and Drug Administration (FDA) approved the Novartis drug AfinitorÂ® (everolimus) for the treatment of advanced pancreatic neuroendocrine tumors.
A new study reports that multipolar electrocoagulation in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett's esophagus over the long term.
Heavy drinking is not associated with one of the two most common types of gullet (oesophageal) cancer, according to this study.
- A volcanic mudflow.